Cargando…
Do we need new trials of procalcitonin-guided antibiotic therapy? A response
Autores principales: | van Oers, Jos A. H., Nijsten, Maarten W., de Lange, Dylan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865370/ https://www.ncbi.nlm.nih.gov/pubmed/29566764 http://dx.doi.org/10.1186/s13054-018-2008-y |
Ejemplares similares
-
Do we need new trials of procalcitonin-guided antibiotic therapy?
por: Lisboa, Thiago, et al.
Publicado: (2018) -
Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients
por: Assink-de Jong, Evelien, et al.
Publicado: (2013) -
Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands
por: Kip, Michelle M. A., et al.
Publicado: (2018) -
Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials
por: Wirz, Yannick, et al.
Publicado: (2018) -
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: some research questions
por: Kahn, Robert E
Publicado: (2009)